02-10-2023 01:20 PM | Source: Sushil Finance
Buy Kilitch Drugs (India) Ltd For Target Rs.254 - Sushil Finance
We have coverage on Kilitch Drugs (India) Ltd with a BUY rating on stock. Since our report, the stock has posted a high of Rs.244 today
With the recent run-up in the share price (36% return), we are now changing our rating on the stock to Neutral and recommend our investors to book profits.
Please refer disclaimer at https://www.sushilfinance.com/Disclamier/disclaimer
Member : BSE/ NSE/ MSEI. SEBI Registration No.-INZ000165135.
To Read Complete Report & Disclaimer
Click Here
Views express by all participants are for information & academic purpose only. Kindly read disclaimer before referring below views. Click Here For Disclaimer
Latest News
Insurance Sector Update : Motor drags down overall g...
Sell Gold Below 72700 SL Above 72950 TGT 72400/72100...
Wipro shares nosedived over 9 pc after missed earnin...
Economic Survey links mental health disorders with '...
India's GDP growth for FY25 to surpass Economic Surv...
Evening Roundup : A Daily Report on Bullion Energy &...
FIIs stood as net buyers in equities as per July 22 ...
Union Budget: Experts urge government to remove 18 ...
Poonawalla Fincorp AUM up 52% YoY to Rs 26,972 crore...
Sensex ends lower ahead of Union Budget 2024-25